Stayble Therapeutics (Sweden) Market Value
| STABL Stock | SEK 0.57 0.02 3.64% |
| Symbol | Stayble |
Stayble Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stayble Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stayble Therapeutics.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Stayble Therapeutics on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Stayble Therapeutics AB or generate 0.0% return on investment in Stayble Therapeutics over 30 days. Stayble Therapeutics is related to or competes with Hansa Biopharma, Saniona AB, and Oncopeptides. Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration More
Stayble Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stayble Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stayble Therapeutics AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 36.33 | |||
| Value At Risk | (8.82) | |||
| Potential Upside | 10.77 |
Stayble Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stayble Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stayble Therapeutics' standard deviation. In reality, there are many statistical measures that can use Stayble Therapeutics historical prices to predict the future Stayble Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (1.59) | |||
| Treynor Ratio | (1.91) |
Stayble Therapeutics Backtested Returns
Stayble Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0555, which indicates the firm had a -0.0555% return per unit of risk over the last 3 months. Stayble Therapeutics AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stayble Therapeutics' Coefficient Of Variation of (1,728), risk adjusted performance of (0.04), and Variance of 49.7 to confirm the risk estimate we provide. The entity has a beta of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Stayble Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Stayble Therapeutics is expected to be smaller as well. At this point, Stayble Therapeutics has a negative expected return of -0.39%. Please make sure to validate Stayble Therapeutics' total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Stayble Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Stayble Therapeutics AB has very weak reverse predictability. Overlapping area represents the amount of predictability between Stayble Therapeutics time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stayble Therapeutics price movement. The serial correlation of -0.01 indicates that just 1.0% of current Stayble Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Stayble Therapeutics lagged returns against current returns
Autocorrelation, which is Stayble Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Stayble Therapeutics' stock expected returns. We can calculate the autocorrelation of Stayble Therapeutics returns to help us make a trade decision. For example, suppose you find that Stayble Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Stayble Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Stayble Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Stayble Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Stayble Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Stayble Therapeutics Lagged Returns
When evaluating Stayble Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Stayble Therapeutics stock have on its future price. Stayble Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Stayble Therapeutics autocorrelation shows the relationship between Stayble Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Stayble Therapeutics AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.